Ship in Europe, Find out rates!
Levoreact Nasal Spray 10 ml 0.5 mg is used in the symptomatic treatment of allergic rhinitis.
Levoreact Nasal Spray 10 ml 0.5 mg for Allergic Rhinitis
Therapeutic indicationsLevoreact Nasal Spray is used in the symptomatic treatment of allergic rhinitis.
Dosage and method of use
Since Levoreact Nasal Spray is available as a microsuspension, the bottle should be shaken before each application.
In case of need, the dose can be repeated up to 3-4 times a day. Treatment should be continued for as long as it takes for symptoms to disappear. The patient should be instructed to blow the nose well before using the product. Before using the preparation for the first time, remove the cap and press two or three times until a regular delivery is obtained.
Contraindications Hypersensitivity to the active substance or to any of the excipients. Generally contraindicated in pregnancy. Special warnings Since levocabastine is predominantly excreted via the kidney, the drug should be administered with caution in patients with renal insufficiency.
Like all nasal preparations containing benzalkonium chloride, propylene glycol and esters, the product can cause skin irritation.
In mice, rats and rabbits, the product, administered at systemic doses up to 1250 times (mg / kg) the maximum recommended clinical nasal dose, did not reveal any embryotoxic or teratogenic effects. In rodents, teratogenicity and / or increased embryonic resorptions have been observed at doses of levocabastine over 2500 times (mg / kg) the maximum nasal dose. There are limited data from its use in pregnant women.
The risk to the man is not known, therefore the drug should not be used during pregnancy, except in cases where the expected benefit to the woman justifies the potential fetal risk.
Based on levocabastine concentration determinations in the saliva and milk of a nursing woman given a single oral dose of 0.5 mg levocabastine, approximately 0.6% of the total nasally administered levocabastine dose can be passed on to the neonate. However, as clinical studies and experimental data are limited, caution is recommended when administering the drug to breastfeeding women.
Expiration and retentionCheck the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored.
Attentiondo not use the medicine after the expiry date indicated on the package.
Composition Levoreact Nasal Spray contains
Active substance: levocabastine hydrochloride 0.54 mg (equivalent to 0.5 mg of levocabastine)
Excipients: propylene glycol, sodium phosphate monohydrate, anhydrous disodium phosphate, hydroxypropylmethylcellulose, polysorbate 80, benzalkonium chloride, edetate disodium, purified water.
Destination | Cost | Detail |
---|---|---|
Italy | €5,90* | 24/72H |
Austria, France, Germany, Slovenia | € 13* | 3 days |
Belgium, Luxembourg, Portugal, Netherlands, Spain | € 14* | 4 days |
Bulgary, Cechia, Hungary, Poland, Romania, Slovakia | € 19* | 5 days |
Denmark, Estonia, Finland, Ireland, Lithuania, Latvia ,Sweden | € 22* | 5 days |
United Kingdom, Switzerland, Greece | € 30* | 7 days |
Canada, USA | € 40 | 7 Days |